TuHURA Biosciences (HURA) Research & Development (2012 - 2026)
TuHURA Biosciences' Research & Development came in at $6.62 million for Q2 2026, up 34.4% from $4.93 million a year earlier and up 26.5% from the prior quarter.
Powered by 
Analysis
TuHURA Biosciences (HURA) Research & Development (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, TuHURA Biosciences reported Research & Development of $22.88 million, up 5.5% year-over-year; for FY2025, it was $20.53 million, up 54.0% from FY2024.
- Research & Development carries a five-year compound annual growth rate of 41.4% (FY2020 to FY2025).
- Going back by year, Research & Development was $13.34 million in FY2024 (+41.8%), $9.4 million in FY2023, $15.17 million in FY2022 (+28.4%) and $11.82 million in FY2021 (+225.5%).
- The Q2 2026 figure represents the highest quarterly Research & Development in data going back to Q1 2012.
- Business Quant data shows HURA's Research & Development at $5.23 million (Q1 2026), $6.06 million (Q4 2025) and $4.97 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | TuHURA Biosciences | 39.19 Mn | 39.19 Mn | - | 6.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.62 Mn |
| Mar 31, 2026 | 5.23 Mn |
| Dec 31, 2025 | 6.06 Mn |
| Sep 30, 2025 | 4.97 Mn |
| Jun 30, 2025 | 4.93 Mn |
| Mar 31, 2025 | 4.58 Mn |
| Sep 30, 2024 | 2.95 Mn |
| Jun 30, 2024 | 2.82 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 111,000.00 |
| Sep 30, 2023 | 1.86 Mn |
| Mar 31, 2023 | 2.01 Mn |
| Dec 31, 2022 | 2.06 Mn |
| Sep 30, 2022 | 3.17 Mn |
| Jun 30, 2022 | 4.00 Mn |
| Mar 31, 2022 | 3.47 Mn |
| Dec 31, 2021 | 3.90 Mn |
| Sep 30, 2021 | 3.79 Mn |
| Jun 30, 2021 | 4.03 Mn |
| Mar 31, 2021 | 3.84 Mn |
API Access
TuHURA Biosciences Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=HURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "HURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=HURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();